<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04830514</url>
  </required_header>
  <id_info>
    <org_study_id>262424</org_study_id>
    <nct_id>NCT04830514</nct_id>
  </id_info>
  <brief_title>Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics</brief_title>
  <official_title>Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized study to demonstrate how animal-based protein-rich food sources can be used by&#xD;
      older adults to increase protein intake within pre-existing dietary patterns.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Current dietary patterns of older Americans will be augmented by readily available quality&#xD;
      protein sources. Investigators will observe the effects of recommended and common protein&#xD;
      intakes on the maintenance of whole-body protein balance and potential for muscle protein&#xD;
      anabolism.&#xD;
&#xD;
      3 groups of 10 older subjects will be studied during daily protein intakes. Study duration&#xD;
      per subject will be about 2 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 27, 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whole Body Protein Turnover</measure>
    <time_frame>24 hour</time_frame>
    <description>Isotope Tracer</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Recommended dietary allowance (RDA) for protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(RDA; 0.8g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Habitual protein intake consistent with population level norms</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(NHANES; 1.0g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimal protein intake (OPI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(OPI; 1.5g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recommended Dietary Allowance of Protein</intervention_name>
    <description>0.8 g/kg/day protein intake</description>
    <arm_group_label>Recommended dietary allowance (RDA) for protein</arm_group_label>
    <other_name>RDA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Habitual protein intake</intervention_name>
    <description>1.0 g/kg/day protein intake</description>
    <arm_group_label>Habitual protein intake consistent with population level norms</arm_group_label>
    <other_name>NHANES</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optimal Protein Intake</intervention_name>
    <description>1.5 g/kg/day protein intake</description>
    <arm_group_label>Optimal protein intake (OPI)</arm_group_label>
    <other_name>OPI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI â‰¤ 35 kg/m2&#xD;
&#xD;
          -  Capable of providing informed consent&#xD;
&#xD;
          -  COVID-19 negative and/or asymptomatic&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject who does not/will not eat animal protein sources.&#xD;
&#xD;
          -  Body mass index &gt; 35.&#xD;
&#xD;
          -  History of chemotherapy or radiation therapy for cancer in the 6 months prior to&#xD;
             enrollment.&#xD;
&#xD;
          -  Use of insulin to control blood sugar level.&#xD;
&#xD;
          -  Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I)&#xD;
             therapy.&#xD;
&#xD;
          -  Currently using prescription blood thinning medications.&#xD;
&#xD;
          -  Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3.&#xD;
&#xD;
          -  Unwilling to avoid using protein or amino-acid supplements during participation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arny A Ferrando, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Scott Schutzler</last_name>
    <phone>(501) 526-5734</phone>
    <email>SESchutzler@uams.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samantha Seale</last_name>
    <phone>501) 320-7602</phone>
    <email>SSeale@uams.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arny Ferrando, MD</last_name>
      <phone>501-526-5711</phone>
      <email>aferrando@uams.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>April 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>muscle loss</keyword>
  <keyword>protein</keyword>
  <keyword>animal-based protein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

